• 1
    Gold MR, Siegel JE, Russell L, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press, 1996.
  • 2
    CDC Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002;287:254251.
  • 3
    Clarke PM, Gray AM, Briggs A, et al. Cost-utility analyses of intensive blood glucose and tight blood pressure control in Type 2 diabetes (UKPDS 72). Diabetologia 2005;48:86877.
  • 4
    American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 2004;27:22625.
  • 5
    Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 68) Outcomes Model. Diabetologia 2004;47:174759.
  • 6
    Palmer AJ, Roze S, Valentine WJ, et al. The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (Type 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res 2004;20(Suppl.):S526.
  • 7
    Ray JA, Valentine WJ, Secdnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany Italy and Spain. Curr Med Res Opin 2005;21:161729.
  • 8
    Commonwealth Department of Health and Family Services. Development of the Australian Refined Diagnosis Related Groups (AR-DRG) Classification Version 4: Volume 1. Canberra: Commonwealth of Australia, 1998.
  • 9
    Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice of decision analytic modelling in health care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value Health 2003;6:917.
  • 10
    Kelman CW, Bass AJ, Holman CD. Research use of linked health data—a best practice protocol. Aust N Z J Public Health 2002;26:2515.
  • 11
    Australian Bureau of Statistics. 2001 Census Basic Community Profiles and Snapshots. 2002. Available from:[Accessed September 14, 2005].
  • 12
    Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on health care costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study, 65). Diabet Med 2003;20:44250.
  • 13
    O'Brien JA, Shomphe LA, Kavanagh PL, et al. Direct medical costs of complications from type 2 diabetes mellitus in the US. Diabetes Care 1998;21:11228.
  • 14
    Preen DB, Holman CD, Lawrence DM, et al. Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol 2004;57:1295304.
  • 15
    Commonwealth Department of Health and Aged Care. Report on the national hospital cost data collection 1997–1998 (Round 2). Canberra: AGPS, 1999.
  • 16
    Duckett SJ. Casemix funding for acute hospital inpatient services in Australia. Med J Aust 1998;169(Suppl.):S1721.
  • 17
    Australian Bureau of Statistics. Consumer Price Index, Australia. 2005. Available from:[Accessed September 14, 2005].
  • 18
    Hsiao C. Analysis of Panel Data (2nd ed.). Cambridge: Cambridge University Press, 2003.
  • 19
    Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics 2005;6:93109.
  • 20
    Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998;17:24781.
  • 21
    Commonwealth Department of Human Services and Health. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee Including Major Submissions Involving Economic Analyses. Canberra: Australian Government Publishing Service, 1995.
  • 22
    Clarke P, Kelman C, Colagiuri S. Factors influencing the cost of hospital care for people with diabetes in Australia. J Diabetes Complications 2006;20:34955.
  • 23
    Morris AD, Boyle DIR, McAlpine R, et al. The diabetes audit in Tayside Scotland (darts) study: electronic record linkage to create a diabetes register. BMJ 1997;315:5248.
  • 24
    Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity Lifestyle Study (AUSDIAB). Diabetes Care 2002;25:82934.
  • 25
    Phelps CE. Information diffusion and best practice adoption. In: CulyerAJ, NewhouseJP, eds. Handbook of Health Economics. Amsterdam: Elsevier, 2000.

Supplementary materials for this article can be found at: